-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
The current incidence of non-alcoholic fatty liver is getting higher and higher.
The current incidence of non-alcoholic fatty liver is getting higher and higher.
As of December 30, 2020, researchers have searched PubMed, Scopus and Web of Science databases using pre-defined keyword systems to identify observational cohort studies conducted in individuals.
diagnosis
The results of the study showed that the risk of NAFLD and gastrointestinal cancer (esophageal cancer, stomach cancer , pancreatic cancer or colorectal cancer) increased nearly 1.
Stomach cancer pancreatic cancer breast cancer diabetes
This large meta-analysis showed that NAFLD is associated with an increased long-term risk of extrahepatic cancer (especially gastrointestinal cancer, breast cancer, and gynecological cancer) in the past 6 years.
This large meta-analysis showed that NAFLD is associated with an increased long-term risk of extrahepatic cancer (especially gastrointestinal cancer, breast cancer, and gynecological cancer) in the past 6 years.
Original source:
Alessandro Mantovani.
bmj.
com/content/early/2021/03/07/gutjnl-2021-324191" target="_blank" rel="noopener">Non-alcoholic fatty liver disease and increased risk of incident extrahepatic cancers: a meta-analysis of observational cohort studies.
Leave a message here